Antipsychotic Medication: Monitoring Side Effects
|
|
- Godfrey Bradford
- 6 years ago
- Views:
Transcription
1 Antipsychotic Medication: Monitoring Side Effects
2 Aims Review national practice guidelines and evidence regarding current standards of care. Discuss clinical implications of AP side effects. Reflect on personal practice. Consider how to address challenges associated with monitoring AP tolerability.
3 Context: Scope of the Problem Individual response to AP treatment unpredictable. Lack of reliable data on prevalence of side effects. Survey data indicate that side effects are common and distressing.
4 Second-generation ( atypical ) AP Side Effect Profiles Amisulpride (Solian ) Aripiprazole (Abilify ) Drug Clozapine (Clozaril, Denzapine, Zaponex ) Olanzapine (Zyprexa ) Paliperidone (Invega ) Risperidone (Risperdal ) Usual daily dose mg 15-30mg Sedation Movement problems Weight gain Antichol inergic Sexual problems Usually mg 10-20mg 6mg 4-6mg Quetiapine (Seroquel ) Zotepine (Zoleptil ) Around 600mg Up to 300mg
5 First-generation ( typical ) AP Side Effect Profiles Drug Chlorpromazine Haloperidol Levomepromazine Pericyazine Perphenazine Usual daily dose mg 5-20mg mg 5-20mg 12-24mg Sedation Movement problems Weight gain Anticholinergic Sexual problems Sulpiride 400-1,600mg Trifluoperazine 5-15mg
6 Long-acting injectable AP Side Effect Profiles Drug Usual dose Sedation Movement problems Weight gain Antichol inergic Sexual problems Flupenthixol decanoate (Depixol ) Fluphenazine decanoate (Modecate ) Haloperidol decanoate (Haldol decanoate ) Pipothiazine palmitate (Piportil ) Zuclopenthixol decanoate (Clopixol ) Risperidone (Risperdal Consta ) mg a fortnight mg a fortnight mg a month 25-50mg a fortnight 25-50mg a fortnight 25-50mg a fortnight
7 Reflection on Current Practice How do you typically monitor the side effects associated with AP medication? How do you evidence any monitoring that you undertake? Are there any side effects that you do not tend to ask patients about? If so, why? Are there any factors that may prevent you from monitoring AP side effects on a routine basis?
8 National Practice Guidance AP side effects should be monitored routinely and regularly (NICE, 2002). People receiving depot preparations should be maintained under regular clinical review, particularly in relation to the risks and benefits of the drug regimen (NICE, 2002). Where a potential to cause weight gain or diabetes has been identified (or included in the Summary of Product Characteristics) for the atypical antipsychotic being prescribed, there should be routine monitoring in respect of these potential risks. (NICE, 2002) Note: The NICE guidance for the treatment of Schizophrenia is currently under review. The revised guideline is due to be published in 2009.
9 Current Practice Standards: The National Picture June 2008: National audit of side monitoring for patients prescribed depot AP medication. Participants: 500 clinical teams from 38 specialist mental health trusts. Sample: 5,804 patient case notes reviewed. Audit standard: All patients prescribed depot/long-acting injectable antipsychotic (AP) medication should have a review of side effects at least once a year.
10 Key findings from POMH-UK audit Total number of patient case notes reviewed = 5,804 Nature of documented evidence: % No documented evidence 35% General statement that side effects are not present 26% General statement that side effects are present 28% Physical examination to assess side effects 11% Blood tests related to side effects 12% Local Trust checklist or rating scale 4% Published side effect rating scale 8% Scale designed by pharmaceutical company 1%
11 Evidence of assessment of specific side effects during the previous year Total number of patient case notes reviewed = 5,804 Evidence of assessment of movement disorders Evidence of assessment of weight/bmi/waist circumference Evidence of assessment of sexual side effects Evidence of assessment of menstrual disturbance (female patients under 50) % 31% 27% 9% 15% (Total no. of women <50: 1,043)
12 Clinical implications of AP side effects Physical health complications. Confound assessment of clinical condition. Functional impairment Social stigma. Negative attitudes towards AP treatment.
13 Monitoring AP side effects: A challenging clinical task Have you experienced any difficulties identifying or monitoring AP side effects when working with patients? Please describe any examples.
14 Monitoring AP side effects: A challenging clinical task Side effects can be difficult to distinguish from symptoms of the illness or other conditions. Baseline assessment. Ongoing monitoring. Use of symptom checklists or side effect rating scales.
15 Be specific! Monitoring AP side effects: A challenging clinical task Reliance on observation, or waiting for patients to report problems with their medication. Ongoing patient education. Written materials supported by open discussion. Involve carers/relatives.
16 Monitoring AP side effects: A challenging clinical task Communication barriers. Self-report symptom checklists. Written information - a way in to discussions about intimate side effects. Make routine questioning about medication the norm.
17 Monitoring AP side effects: A challenging clinical task Raising a patient s awareness of side effects may prompt them to stop taking their AP medication. No evidence to support this assumption. Patients appreciate open communication about their medication. Unexpected side effects may be more frightening.
18 Monitoring AP side effects: A challenging clinical task Physical health monitoring Know who is responsible for routine physical health checks. Ensure service user knows and agrees who should be responsible. Ensure responsibilities for physical health monitoring are documented.
19 Monitoring AP side effects: A challenging clinical task You just have to put up with AP side effects because there is little that can be done about them. Medication changes. Practical advice. Identify physical health complications early.
20 Practical tips for managing side effects Side effect Constipation Urinary retention Dry mouth Weight gain Movement disorders Sexual side effects Menstrual disturbance Examples of practical management tips Dietary advice: plenty of fruit and veg, high-fibre foods and fluids, preferably water. Medication options, e.g. lactulose, Fibogel. Older men may need to see their Doctor to rule out prostrate problems. Sip water regularly. Advise against too many sugary drinks. Recommend regular dental check-ups. Try sucking sugar-free sweets or sugar-free gum. Try an artificial saliva spray (e.g. Glandosane spray). Food diaries to spot eating habits. Control calorie intake weigh portions. Support service user to set realistic weight loss targets. Referral to a dietician. Referral to prescriber for review of dose/type of medication. Distraction techniques (e.g. exercise to alleviate subjective symptoms of akathisia). Work with patient to identify likely cause of problem. Consider weight, depression, stress, relationship problems and health issues (e.g. diabetes for men). Recommend use of a lubricant if female patients complain of painful sex. Refer patient to prescriber for a medication review. Consider whether patient may need contraceptive advice.
21 Reflection on Current Practice Could you improve the way in which you monitor AP side effects? How? What problems do you think you may encounter if you have identified steps that you can take to improve your practice? Is there anything you can do to address these? Do you need any additional support (e.g. systems, training) to enable you to monitor AP tolerability more effectively?
22 Summary Baseline assessment. Routine monitoring. Specific questions. General enquiry and observation are not enough. Document. Ongoing patient education. Involve carers/relatives. Know who is responsible for physical health monitoring.
23 Online resources General information about medication: Website of the UK Psychiatric Pharmacy Group. Enables you to search for information by condition and contains frequently asked questions about psychiatric medication. (At the time of writing, this website was still in the process of being developed, so some sections may not yet be complete). Enables you to search for information about specific drugs by name, including patient information leaflets and Summaries of Product Characteristics. Information about mental health conditions and drug treatment: National Institute of Mental Health (USA) website. Select the Health and Outreach tab at the top of the home page. The website of the Royal College of Psychiatrists. Contains easy-to-read information leaflets designed for the general public. Select Mental Health Information. User organisation websites with information about drug treatment: Click on about mental illness, then select the condition you are interested in from the drop-down menu where it says mental illnesses and disorders. Select information, then factsheets and booklets. Select about mental illness.
24 Online resources General information about health conditions NHS clinical knowledge website, which allows you to search by a specific illness or medical topic. Contains information leaflets for patients. The guide to diabetes link (at the top of the home page) contains information about diabetes that may be useful for patients who have recently been diagnosed with the condition. Healthy eating & lifestyle advice Food Standards Agency website contains lots of advice about healthy eating and how to interpret labels on food. Contains a BMI calculator. Website of the British Dietetic Association. Contains a publications and resources section with information leaflets that you can download free of charge.
25 References describing side effect checklists or rating scales Dassori, A.M., Miller, A.L., Weiden, P.J. (2003) The Approaches to Schizophrenia Communication (ASC) Tool. Including the Patient Perspective in Treatment. Disability Management and Health Outcomes, 11, Day, J.C., Wood, G., Dewey, M., & Bentall, R.P. (1995). A self-rating scale for measuring neuroleptic side-effects. Validation in a group of schizophrenic patients. The British Journal of Psychiatry, 166, (Describes the development and testing of the Liverpool University Neuroleptic Side Effect Rating Scale, known as the LUNSERS). Jordan, S., Knight, J., & Pointon, D. (2004) Monitoring adverse drug reactions: Scales, profiles, and checklists. International Nursing Review, 51, Waddell, L. & Taylor, M. (2008) A new self-rating scale for detecting atypical or second-generation antipsychotic side effects. Journal of Psychopharmacology, 22,
26 Terminology First-generation APs Typicals Second-generation APs Atypicals Depot Extrapyramidal symptoms/side effects (EPS) Dystonia Parkinsonism Akathisia Tardive dyskinesia Term sometimes used to refer to older APs developed during the 50s/60s). Haloperidol and chlorpromazine are examples of first-generation APs. See above. Another term used to described older APs. Term used to refer to newer APs developed since the late 1980s. Examples include: clozapine, olanzapine and risperidone. See above. Another term used to describe the newer APs. An long-acting injectable form of medication. Depot APs are injected intramuscularly, usually every 2 to 6 weeks. Movement disorders associated with APs. These include parkinsonian symptoms, dystonic reactions, akathisia and tardive dyskinesia. Sustained muscle contractions, resulting in contorted, twisting or repetitive movements or abnormal postures. These typically affect the muscles of the head and neck. Symptoms characteristic of Parkinson s Disease: rigid muscles, tremor and slow movement. An unpleasant sense of inner restlessness, which often leads patients to feel as if they need to be moving all the time. Abnormal repetitive movements that the patient has no control over, which may appear strange to others. These usually affect the mouth and face, but can affect any body part.
27 Terminology (cont.) Anticholinergic (also known as antimuscarinic ) side effects Metabolic syndrome Body Mass Index (BMI) Hyperprolactinaemia Amenorrhoea Gynaecomastia Galactorrhoea A group of side effects that are believed to be caused when medicines block cholinergic receptors in the brain. The following are anticholinergic side effects associated with some APs (e.g. olanzapine, clozapine) and some medicines prescribed to treatment movement disorders (e.g. procyclidine): constipation, urinary retention, blurred vision, dry mouth, cognitive/memory problems. A cluster of symptoms, each of which is independently associated with an increased risk of developing cardiovascular disease and type 2 diabetes mellitus. Different diagnostic criteria have been proposed for the metabolic syndrome, but they all share the following components: glucose intolerance, obesity, hypertension and dyslipidaemia (low plasma levels of high-density lipoprotein cholesterol and elevated levels of triglycerides). Weight (kgs) divided by height (metres squared). Healthy BMI: Overweight: Obese = > 30. Abnormally high levels of the hormone prolactin. Symptoms associated with hyperprolactinaemia include menstrual irregularities (female patients), tender, swollen nipples and a milky discharge from the nipples (both sexes). Loss of periods for three months or more. (Symptom of hyperprolactinaemia). Sore, swollen, uncomfortable nipples or chest. (Symptom of hyperprolactinaemia). A milky discharge from the nipples. (Symptom of hyperprolactinaemia).
This factsheet covers:
Antipsychotics If you experience psychosis as part of your illness, you may be offered antipsychotic medication. Antipsychotics are generally used to treat psychosis, but are also used to treat bipolar
More informationAntipsychotics. This factsheet covers -
Antipsychotics If you experience psychosis as part of an illness, you may be offered antipsychotic medication. Antipsychotics are generally used to treat psychosis, but are also used to treat bipolar disorder
More informationDatix Ref:
Title Document Details Shared Care Agreement: Antipsychotics (Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine) Trust Ref No 2081-38933 Local Ref (optional) Main points the document
More informationMental Health Medicines Management Pilot. Community Pharmacy. High Dose Antipsychotic Screening, Education & Advice Service
Mental Health Medicines Management Pilot Community Pharmacy High Dose Antipsychotic Screening, Education & Advice Service Approved Version 1 Date of First Issue Review Date Date of Issue Author / Contact
More informationPreferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses
Preferred Prescribing Choices of Antipsychotic Drugs (APD) in Adults for Schizophrenia and Other Psychoses HPFT Medicines Formulary lists the APDs that have been approved for use, however, it does not
More informationESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine
Ref No: E053 ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride or Asenapine NOTE: Please complete details on P1 &3 Send one copy to GP, Patient and file
More informationESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only)
E099 ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, Amisulpride (South Staffordshire Only) NOTE: Please complete details on P1 &3 Send one copy to GP, Patient and
More informationSHARED CARE GUIDELINE
SHARED CARE GUIDELINE Title: Prescribing and/ or Monitoring of Antipsychotics Scope: Pennine Care NHS Foundation Trust NHS Bury NHS Oldham NHS Heywood, Middleton and Rochdale NHS Stockport NHS Tameside
More informationESSENTIAL SHARED CAR E AGREEMENT FOR
E093 ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, or Amisulpride for Behavioural indications in People with Learning Disability (LD) Referral Criteria In some
More informationESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, or Amisulpride for Behavioural indications in DNLD
Ref No: E050 ESSENTIAL SHARED CARE AGREEMENT FOR Risperidone, Olanzapine, Quetiapine, Aripiprazole, or Amisulpride for Behavioural indications in DNLD Please complete the following details: Patient s name,
More informationAntipsychotics. BMF 84 - Antipsychotics
Antipsychotics BMF 84 - Antipsychotics Antipsychotic medications (neuroleptics) are used for the treatment of psychosis, mainly schizophrenia and manic depression (bipolar disorder). They reduce symptoms
More informationWhat Team Members Other Than Prescribers Need To Know About Antipsychotics
What Team Members Other Than Prescribers Need To Know About Antipsychotics The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State
More informationMinimising the Impact of Medication on Physical Health in Schizophrenia
Minimising the Impact of Medication on Physical Health in Schizophrenia John Donoghue Liverpool Imagination is more important than knowledge Albert Einstein LIFESTYLE Making choices TREATMENT Worse Psychopathology,
More informationSHARED CARE GUIDELINE
SHARED CARE GUIDELINE Title: Shared Care Guideline for the prescribing and monitoring of Antipsychotics for the treatment of Schizophrenia and psychotic symptoms in children and adolescents Scope: Pennine
More informationTreatment of Schizophrenia Appendix Three Page 1 of 8
Prescribing Guidelines Treatment of Schizophrenia Scope of this guidance This guidance aims to describe the pharmacological management of schizophrenia at a simple and intermediate level, with a brief
More informationThe routine use of Intramuscular anticholinergics and depot antipsychotics BY DR. CHANTELLE MAGRI FOUNDATION YEAR 1
The routine use of Intramuscular anticholinergics and depot antipsychotics BY DR. CHANTELLE MAGRI FOUNDATION YEAR 1 Contributors Dr. Francesca Falzon Aquilina; BST psychiatry Dr Claire Axiaq; Resident
More informationMichael J. Bailey, M.D. OptumHealth Public Sector
Michael J. Bailey, M.D. OptumHealth Public Sector LIHP Quality Charter To ensure the quality of care delivered to enrollees in San Diego County Assistance Programs, such as County Medical Services (CMS)
More informationObjectives. Epidemiology. Diagnosis 3/27/2013. Identify positive and negative symptoms used for diagnosis of schizophrenia
Objectives Identify positive and negative symptoms used for diagnosis of schizophrenia Mohamed Sallout, Pharm D. Pharmacist Resident St. Luke s Magic Valley Regional Medical Center List medications used
More informationFormulary Item Restrictions and/or Advice Site availability
Formulary Item Restrictions and/or Advice Site availability C&W CNWL Typical Antipsychotic drugs Chlorpromazine 25mg Chlorpromazine 50mg Chlorpromazine 100mg Chlorpromazine 25mg/5ml syrup Chlorpromazine
More informationDepots Improving patient care?
Depots Improving patient care? Caroline Parker Consultant Pharmacist NAPICU Conference 9 th September 2010 Depots Coercion Paternalistic Degrading Standard treatment Necessary Old fashioned Forced Easier
More informationChapter 17. Psychoses. Classifications of Psychoses. Schizophrenia. Factors Attributed to Development of Psychoses
Chapter 17 Psychoses Drugs for Psychoses Delusions Hallucinations Illusions Paranoia Upper Saddle River, New Jersey 07458 All rights reserved. Classifications of Psychoses Acute episode Chronic episode
More informationDocument Title Antipsychotics Prescribing Guidelines for Schizophrenia
Document Title Antipsychotics Prescribing Guidelines for Schizophrenia Document Description Document Type Prescribing Guidance Service Application Medicines Management Version 1.0 Policy Reference no.
More informationAntipsychotic Medication
Antipsychotic Medication Mary Knutson, RN 3-7-12 Mosby items and derived items 2009 by Mosby, Inc., an affiliate of Elsevier Inc. 1 Clinical Uses of Antipsychotics Short-term: in severe depression and
More informationSevere Mental Illness and Diabetes. Charlie Place
Severe Mental Illness and Diabetes Charlie Place Intro Me Community Mental Health Nurse Case manager for Assertive Outreach Team in Leeds Severe Mental Illness (SMI) usually diagnosis of schizophrenia
More informationMEDICINES MANAGEMENT TOOL FOR ANTIPSYCHOTICS
MEDICINES MANAGEMENT TOOL FOR ANTIPSYCHOTICS Document Reference G368 Version Number 4.0 Author/Lead Job Title Wendy Tucker Jackie Stark Alberto Ortiz-Moya Date last reviewed, (this version) August 2017
More informationSiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA. [compatible with NICE guidance]
SiGMA/ MMHSCT GUIDELINES FOR ANTIPSYCHOTIC DRUG TREATMENT OF SCHIZOPHRENIA [compatible with NICE guidance] Medicines Management Committee August 2002 For review August 2003 Rationale The SiGMA algorithm
More informationMMG012 GUIDELINES FOR THE USE OF HIGH DOSE ANTIPSYCHOTIC MEDICATION
MMG012 GUIDELINES FOR THE USE OF HIGH DOSE ANTIPSYCHOTIC MEDICATION Page 1 of 16 Table of Contents Why we need this Policy... 3 What the Policy is trying to do... 3 Which stakeholders have been involved
More informationAntipsychotic Prescribing Audit:
Antipsychotic Prescribing Audit: Measuring the impact of a prescribing intervention Audit Co-ordinator/ Author of Report: Supervisor: Professor Shôn W Lewis Table of Contents List of Tables... 3 List of
More informationHigh Dose Antipsychotic Therapy (HDAT) guideline
Document level: Trustwide (TW) Code: MP18 Issue number: 2 High Dose Antipsychotic Therapy (HDAT) guideline Lead executive Medical Director Author and contact number Lead Clinical Pharmacist 01625 663 857
More informationHearts and Minds An ECG Update. Tuesday 18 th November The Met Hotel, Leeds
Hearts and Minds An ECG Update Tuesday 18 th November The Met Hotel, Leeds Ashleigh Bradley Specialist Clinical Pharmacist for Mental Health and Lithium Clinic Airedale NHS Foundation Trust Introduction
More informationSchizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM
Schizophrenia Pharmacology UNIVERSITY OF HAWAI I HILO PRE -NURSING PROGRAM NURS 203 GENERAL PHARMACOLOGY DANITA NARCISO PHARM D Learning Objectives Understand the result of dopamine binding to D2 receptors
More informationDebra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist. HMS Training Webinar January 27, 2017
Debra Brown, PharmD, FASCP Pharmaceutical Consultant II Specialist HMS Training Webinar January 27, 2017 1 Describe nationwide prevalence and types of elderly dementia + define BPSD Define psychotropic
More informationS H A R E D P R E S C R I B I N G G U I D E L I N E
S H A R E D P R E S C R I B I N G G U I D E L I N E Introduction This shared prescribing guideline for the second generation antipsychotic medications listed above has been developed with due consideration
More informationMedication Audit Checklist- Antipsychotics - Atypical
Medication Audit checklist Page 1 of 7 10-2018 Audit number: Client number: Ordering Provider: INDICATIONS 1) Disorders with psychotic symptoms (schizophrenia, schizoaffective disorder, manic disorders,
More informationSHARED CARE GUIDELINE
SHARED CARE GUIDELINE Shared Care Guideline for the prescribing and monitoring of antipsychotics for the treatment of Neurodevelopmental Disorders in children and adolescents. Scope: Version 1 Pennine
More informationHigh Dose Antipsychotic Medication Policy
High Dose Antipsychotic Medication Policy Policy Title State previous title where relevant State if Policy New or Revised Policy Strand Org, HR, Clinical, H&S, Infection Control, Finance For clinical policies
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 30 November 2011
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 30 November 2011 List of medicines concerned: SECOND-GENERATION ORAL ANTIPSYCHOTICS SOLIAN 100 mg, 200 mg, 400 mg
More informationANTIPSYCHOTICS/ NEUROLEPTICS
Pharmacological Interventions Tutorial Antipsychotic medications First Generation (Typicals) Includes phenothiazines, thioxanthenes, butyrophenones ANTIPSYCHOTICS/ NEUROLEPTICS Second Generation (Atypicals)
More informationSchizophrenia: core interventions in the treatment and management of schizophrenia
Schizophrenia: core interventions in the treatment and management of schizophrenia A guide for people with schizophrenia, their advocates and carers, and the public Information for the public (2 nd consultation)
More informationPharmacy Medical Necessity Guidelines: Antipsychotic Medications
Pharmacy Medical Necessity Guidelines: Antipsychotic Medications Effective: July. 1, 2016 Prior Authorization Required Type of Review Care Management Not Covered Type of Review Clinical Review Pharmacy
More informationDepot Antipsychotics
Depot Antipsychotics Traffic light classification - Amber 2 Information sheet for Primary Care Healthcare Professionals Scope These guidelines are to support primary care healthcare professionals who are
More informationChapter 161 Antipsychotics
Chapter 161 Antipsychotics Episode Overview Extrapyramidal syndromes are a common complication of antipsychotic medications. First line treatment is benztropine or diphenhydramine. Lorazepam is used in
More informationClinical. High Dose Antipsychotic Prescribing Procedures. Document Control Summary. Contents
Clinical High Dose Antipsychotic Prescribing Procedures Document Control Summary Status: Version: Author/Owner/Title: Approved by: Ratified: Related Trust Strategy and/or Strategic Aims Implementation
More informationAbbreviated Class Review: Long-Acting Injectable Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationObjectives. Antipsychotics 7/25/2016. LeadingAge Florida 53rd Annual Convention & Exposition
Reducing the Use of Antipsychotics in Long Term Care Communities Alan W. Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy Objectives Recognize the clinical evidence for the need to change
More informationAbbreviated Class Review: Long-Acting Injectable Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35, Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationDr. Ken Courtenay FRCPsych MRCGP Consultant Psychiatrist in Intellectual Disability. London UK
Dr. Ken Courtenay FRCPsych MRCGP (k.courtenay@ucl.ac.uk) Consultant Psychiatrist in Intellectual Disability London UK EAMHID Zagreb 27.4.2018 Overuse of Medication in People with ID Clinical Background
More informationThis shared care protocol covers when atypical antipsychotics are prescribed for the treatment of
SHARED CARE PROTOCOL for ATYPICAL ANTIPSYCHOTICS SCOPE Greater Manchester West Mental health NHS Foundation Trust Bolton Primary Care Trust Salford Primary Care Trust Trafford Primary Care Trusts Issue
More informationPrescription of High Dose Antipsychotic Medication
Subject (M1) Title Medicine Prescription of High Dose Antipsychotic Medication Manual Mental Health Procedure No M1-P-2-MH Department Pharmacy Distribution All Author Rae McKnight Review 4 Reviewer Jonathan
More informationAntipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients
Antipsychotics Prior Authorization Criteria for Louisiana Fee for Service and MCO Medicaid Recipients Preferred Agents (Oral) a Amitriptyline/Perphenazine (Generic) Aripiprazole Tablet (Generic) b Chlorpromazine
More informationPreventing obesity and staying a healthy weight
Understanding NICE guidance Information for the public Preventing obesity and staying a healthy weight NICE advises the NHS on caring for people with specific conditions or diseases. It also advises the
More informationFasting total cholesterol, LDL cholesterol, HDL cholesterol and triglycerides (if fasting levels are not already available) *
Antipsychotic Shared Care and Physical Health Monitoring Recommendations Version 5 INDICATION - All patients on antipsychotics for chronic psychiatric illness Consultant/Specialist Care Services will initiate
More informationNHS Grampian Guidance For Staff Working In The Mental Health Service For The Use Of High-Dose Antipsychotic Medication
NHS Grampian Westholme Woodend Hospital Queens Road ABERDEEN AB15 6LS Date 20 th November 2014 Our Ref HDAT_MGPG/Nov14 Enquiries to Caroline Hind Extension 56088 Direct Line 01224 556088 Email caroline.hind2@nhs.net
More informationAuthorised by Greater Medicines Management Group
SHARED CARE PROTOCOL for ATYPICAL ANTIPSYCHOTICS SCOPE Greater Manchester West Mental health NHS Foundation trust Bolton Primary Care Trust Salford Primary Care Trust Trafford Primary Care Trusts Issue
More informationSAFETY AND TOLERABILITY: HOW DO NEWER GENERATION ATYPICAL ANTIPSYCHOTICS COMPARE?
Psychiatric Quarterly, Vol. 73, No. 4, Winter 2002 ( C 2002) SAFETY AND TOLERABILITY: HOW DO NEWER GENERATION ATYPICAL ANTIPSYCHOTICS COMPARE? Rajiv Tandon, M.D. Previously, clinicians worked with antipsychotic
More informationGuidelines on Choice and Selection of Antipsychotics for the Management of Psychosis and Schizophrenia in Adults
Working in partnership: Hertfordshire Partnership University NHS Foundation Trust East and North Hertfordshire Clinical Commissioning Group Herts Valleys Clinical Commissioning Group Guidelines on Choice
More informationAntipsychotic Medications Age and Step Therapy
Market DC *- Florida Healthy Kids Antipsychotic Medications Age and Step Therapy Override(s) Approval Duration Prior Authorization 1 year Quantity Limit *Virginia Medicaid See State Specific Mandates *Indiana
More informationAntipsychotics. Something Old, Something New, Something Used to Treat the Blues
Antipsychotics Something Old, Something New, Something Used to Treat the Blues Objectives To provide an overview of the key differences between first and second generation agents To an overview the newer
More informationSwitching antipsychotics: Basing practice on pharmacology & pharmacokinetics
Switching antipsychotics: Basing practice on pharmacology & pharmacokinetics John Donoghue Liverpool L imagination est plus important que le savoir Albert Einstein Switching Antipsychotics: Objectives
More informationNew Medications in Early Psychosis
New Medications in Early Psychosis Jean Starling Department of Psychological Medicine, the Children s Hospital at Westmead Department of Psychological Medicine and Department of Paediatrics and Child Health,
More informationSECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS
SECTION 9 : MANAGEMENT OF MOVEMENT DISORDERS AND EXTRAPYRAMIDAL SIDE EFFECTS Formulary and Prescribing Guidelines 9.1 Introduction Movement disorders and extrapyramidal side effects can manifest in the
More informationThe Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability
The Deprescribing of Psychotropic Medication in Service Users (Patients) with Learning Disability Danielle Adams Principal Clinical Pharmacist Pharmacy and Medicines Optimisation Team HPFT July 2017 1
More informationCLOZAPINE. Clozapine, (trade name Clopine and Clozaril in Australia) is a second generation atypical antipsychotic agent.
CLOZAPINE Introduction Clozapine, (trade name Clopine and Clozaril in Australia) is a second generation atypical antipsychotic agent. Due to its potential for significant toxicity, it is reserved for patients
More informationHigh Dose Antipsychotic Therapy (HDAT) guideline
Document level: Trustwide (TW) Code: MP18 Issue number: 4 High Dose Antipsychotic Therapy (HDAT) guideline Lead executive Medical Director Authors details Michael Slater (Clinical Pharmacist, tel. 01625
More informationTable of Contents. 1.0 Policy Statement...1
Division of Medical Assistance General Clinical Policy No. A-6 Table of Contents 1.0 Policy Statement...1 2.0 Policy Guidelines...1 2.1 Eligible Recipients...1 2.1.1 General Provisions...1 2.1.2 EPSDT
More informationGuidance on the Use of Antipsychotic Long-acting Injections in North of England
Guidance on the Use of Antipsychotic Long-acting Injections in North of England This guidance aims to inform and support prescribers within the three mental health service providers in the north of England
More informationTreat Schizophrenia Schizoaffective disorder Bipolar disorder Psychotic depression Off-label uses Insomnia Tics Delirium Stuttering
Robert M. Millay RN MSN Ed Professor, Napa Valley College Psychiatric Technician Programs Copyright 2015, 2011, 2007, 2003, 1999, 1995, 1991 by Mosby, an imprint of Elsevier Inc. Treat Schizophrenia Schizoaffective
More informationRiding the Waves: Tools for the Management of Bipolar Disorder
Riding the Waves: Tools for the Management of Bipolar Disorder Jacintha S. Cauffield, Pharm.D., BCPS, CDE Associate Professor of Pharmacy Practice Palm Beach Atlantic University Lloyd L. Gregory School
More informationAntipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011)
Antipsychotics by Cayte Hoppner (updated by Glenice Bateman, Pharmacist, 2011) Introduction Antipsychotics are the foundation of pharmacological treatment of schizophrenia and other psychotic illnesses.
More informationGuidance on the Use of Antipsychotic Long-acting Injections in North of England (TEWV version)
Guidance on the Use of Antipsychotic Long-acting Injections in North of England (TEWV version) This guidance aims to inform and support prescribers within the three mental health service providers in the
More informationPhysical health of those with serious mental illness.
Physical health of those with serious mental illness. How Compass Health PHO is improving the service for our population Lynley Byrne Clinical Leader Compass Health PHO June 2016 Total Population Compass
More informationFirst Steps: Considering Clozapine for your Patients
First Steps: Considering Clozapine for your Patients The Care Transitions Network National Council for Behavioral Health Montefiore Medical Center Northwell Health New York State Office of Mental Health
More informationNational Clinical Audit of Psychosis (NCAP) Audit of practice form. Notes for completion
National Clinical Audit of Psychosis (NCAP) Audit of practice form tes for completion Audit forms should be completed by the psychiatrist accountable for the patient's care If delegated, the psychiatrist
More informationNursing Process Focus: Patients Receiving Chlorpromazine (Thorazine)
Nursing Process Focus: Patients Receiving Chlorpromazine (Thorazine) Potential Nursing Diagnoses Ineffective Therapeutic Regimen Management Risk for Activity Intolerance, related to side effect of drug
More informationAssessing & Management of side effects: Part 1. medicationmanagement
Assessing & Management of side effects: Part 1 medicationmanagement What side effects of antipsychotic medication do you see in you clinical practice? How do you routinely assess for side effects of medication?
More informationAntipsychotic Medications
TRAIL: Team Review of EVIDENCE REVIEW & RECOMMENDATIONS FOR LTC Behavioural and psychological symptoms of dementia (BPSD) refer to the non-cognitive symptoms of disturbed perception, thought content, mood
More informationSchizophrenia. Ajay Karia, Laura Kravitz and Chetan Shah
Browse CD s Update archive for CPD help www.chemistanddruggist.co.uk/update Update Your weekly CPD revision guide Module 1523 60-second summary Use this article as part of your CPD to help establish patients
More informationMental Health Clinical Pathways Group. The Case for Change
Mental Health Clinical Pathways Group The Case for Change Contents 1. Executive summary 2. Introduction 2.1. What is severe mental illness? 2.2. Findings of the Disability Rights Commission 3. Physical
More informationPROBABLE HEALTH CONSEQUENCES OF NOT TAKING THIS MEDICATION
University Health System PSYCHIATRIC SERVICES ANTIPSYCHOTICS Atypical Neuroleptics Risperdal (Risperidone ) Olanzapine (Zyprexa ) Quetiapine (Seroquel ) Course of Treatment: PURPOSE AND GENERAL INFORMATION
More informationUse of Psychotherapeutic Medications in Children and Adolescents with ASD and ID
Use of Psychotherapeutic Medications in Children and Adolescents with ASD and ID Although not considered first line treatment in children with ASD and ID, depending on the severity of symptoms, some medications
More informationTHIOTHIXENE. THERAPEUTICS Brands Navane see index for additional brand names. Generic? Yes
THIOTHIXENE THERAPEUTICS Brands Navane see index for additional brand names Generic? Yes Class Conventional antipsychotic (neuroleptic, thioxanthene, dopamine 2 antagonist) Commonly Prescribed for (bold
More informationDEPOT ANTIPSYCHOTIC MEDICATION: GUIDELINES FOR PRESCRIBING AND ADMINISTERING
DEPOT ANTIPSYCHOTIC MEDICATION: GUIDELINES FOR PRESCRIBING AND ADMINISTERING DECEMBER 2016 This policy supersedes all previous policies Policy title Depot Antipsychotic Medication: Guidelines for Prescribing
More informationSlide 1. Slide 2. Slide 3. About this module. About this module. Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics
Slide 1 Antipsychotics: The Essentials Module 5 A Primer on Selected Antipsychotics Flavio Guzmán, MD Slide 2 About this module 13 antipsychotics will be studied 3 first generation antipsychotics 10 second
More informationFormulary and Clinical Guideline Document Pharmacy Department Medicines Management Services
Formulary and Clinical Guideline Document Pharmacy Department Medicines Management Services VIOLENCE, AGGRESSION OR SEVERE BEHAVIOURAL DISTURBANCE Introduction During an acute episode or illness, some
More informationCHAPTER 3. Schizophrenia and Antipsychotic Treatment
CHAPTER 3 Schizophrenia and Antipsychotic Treatment What is it? It is a severe, chronic, disabling brain disease Considered to have biological origins but exact unknown 1% of population affected Schizophrenia
More informationConduct Disorder in Children and Young People (CYP 5-18 years of age) RISPERIDONE Effective Shared Care Agreement (ESCA)
E102 Conduct Disorder in Children and Young People (CYP 5-18 years of age) RISPERIDONE Effective Shared Care Agreement (ESCA) Patient details Name: Date of birth: NHS number: Contact details Specialist:
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Invega Sustenna, Invega Trinza) Reference Number: CP.PHAR.291 Effective Date: 12.01.16 Last Review Date: 08.18 Line of Business: Medicaid See Important Reminder at the end of this policy
More informationTreatment of Schizophrenia
Treatment of Schizophrenia Conduct comprehensive assessment and use measurement-based care as found in the Principles of Practice (review pages 4-7). Most importantly assess social support system (housing,
More informationMethod. NeuRA Paliperidone August 2016
Introduction Second generation antipsychotics (sometimes referred to as atypical antipsychotics) are a newer class of antipsychotic medication than first generation typical antipsychotics. Second generation
More informationPRESCRIBING GUIDELINES
The Maudsley The South London and Maudsley NHS Foundation Trust & Oxleas NHS Foundation Trust PRESCRIBING GUIDELINES 10th Edition David Taylor Carol Paton Shitij Kapur informa healthcare Contents Authors
More informationGUIDELINES FOR THE USE OF ARIPIPRAZOLE LONG-ACTING INJECTION (ABILIFY MAINTENA)
GUIDELINES FOR THE USE OF ARIPIPRAZOLE LONG-ACTING INJECTION (ABILIFY MAINTENA) Introduction Aripiprazole long-acting injection (LAI)is licensed for the maintenance treatment of adult patients with schizophrenia
More informationNational Center for Mental Health
National Center for Mental Health 9 de Febrero St., Mandaluyong City Telephone No.: 531-9001 (c/o Dr. Vinluan) Organizational Structure Medical Center Chief II Chief, Medical and Professional Staff (Hospital
More informationThe licensed indications for the use of Clozapine are:- Treatment resistant schizophrenia.
1. Introduction Future Directions CIC will support the use of the antipsychotic Clozapine in all appropriate cases. The purpose of this procedure is to set out the standards for Clinicians, Pharmacists,
More informationHOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET
HOSPITAL BASED INPATIENT PSYCHIATRIC SERVICES (HBIPS) MEASURE SET Kathy Wonderly RN, MSEd, CPHQ Consultant Developed: February, 2013 Most recently revised: December 2018 The Psychiatric Measure Set CMS
More informationKelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009
Kelly E. Williams, Pharm.D. PGY2 Psychiatric Pharmacy Resident April 16,2009 List the antipsychotics most often prescribed Compare and contrast the use and adverse effects experienced in the pediatric
More informationMethod. NeuRA First versus second generation antipsychotics August 2016
Introduction First generation typical are an older class of antipsychotic than second generation atypical. First generation are used primarily to treat positive symptoms including the experiences of perceptual
More informationA Brief Overview of Psychiatric Pharmacotherapy. Joel V. Oberstar, M.D. Chief Executive Officer
A Brief Overview of Psychiatric Pharmacotherapy Joel V. Oberstar, M.D. Chief Executive Officer Disclosures Some medications discussed are not approved by the FDA for use in the population discussed/described.
More informationThe Maudsley Prescribing Guidelines in
The Maudsley Prescribing Guidelines in 11th Edition David Taylor Director of Pharmacy and Pathology South London and Maudsley NHS Foundation Trust; Professor King's College London, London, UK Paton Chief
More informationPERPHENAZINE. THERAPEUTICS Brands Trilafon see index for additional brand names. Generic? Yes
PERPHENAZINE THERAPEUTICS Brands Trilafon see index for additional brand names Generic? Yes Class Conventional antipsychotic (neuroleptic, phenothiazine, dopamine 2 antagonist, antiemetic) Commonly Prescribed
More informationAPPROACH TO PSYCHOSIS IN PRIMARY CARE
APPROACH TO PSYCHOSIS IN PRIMARY CARE Family Medicine Forum 2015 Annual Meeting Toronto, Ontario November 12-14, 2015 Jon Davine, MD, CCFP, FRCP(C) Associate Professor, McMaster University Objectives
More information